Issued 2026-09-16 at $144.43 · now $144.43 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, SPHR has typically landed between $116.32 and $183.53 — a range of −19.5% to +27.1% from the issuance price $144.43.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
1,596 overlapping 1 month windows · 2020-04-09 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($144.43) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where SPHR has typically landed a month from the 2026-09-16 close of $144.43 — the range is history, not a prediction.
- now $144.43 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $148.43 (+2.8%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $133.01–$163.84
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $116.32–$183.53
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2025-02-14 | −34.2% | −35.8% | +0.0% |
| 2025-02-07 | −33.3% | −33.3% | +1.6% |
| 2025-02-10 | −33.2% | −33.7% | +1.0% |
| 3 best | |||
| 2025-04-21 | +62.1% | +0.0% | +62.6% |
| 2023-06-28 | +57.4% | +0.0% | +57.4% |
| 2025-04-17 | +55.6% | −4.3% | +55.6% |
1,596 overlapping windows · 2020-04-09 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~7 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-10 | Charles F. Dolan 2009 Revocable Trust | other | Sale | 53,595 @ $33.76 | $1.8M | −96.8% of holding | −9.5% | +41.4% | 1,790 | Form 4 · filed 2 days after the trade |
| 2025-03-10 | Charles F. Dolan 2009 Revocable Trust | other | Sale | 1,790 @ $34.85 | $62K | −100.0% of holding | −9.5% | +41.4% | 0 | Form 4 · filed 2 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
156 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-10 | DOLAN CHARLES P | director | Award / grant | 1,173 | 20,327 | Form 4 |
| 2026-06-10 | Dolan Kristin A | director | Award / grant | 1,723 | 24,937 | Form 4 |
| 2026-06-10 | DOLAN PAUL JOSEPH | director | Award / grant | 1,173 | 26,935 | Form 4 |
| 2026-06-10 | DOLAN THOMAS CHARLES | director | Award / grant | 1,173 | 29,959 | Form 4 |
| 2026-06-10 | Sweeney Brian | director | Award / grant | 1,173 | 29,959 | Form 4 |
| 2026-06-10 | LHOTA JOSEPH | director | Award / grant | 1,173 | 28,822 | Form 4 |
| 2026-06-10 | LITVIN JOEL M. | director | Award / grant | 1,173 | 25,256 | Form 4 |
| 2026-06-10 | Perelman Debra Golding | director | Award / grant | 1,833 | 6,230 | Form 4 |
| 2026-06-10 | SYKES JOHN L | director | Award / grant | 1,173 | 27,092 | Form 4 |
| 2026-06-10 | Thomas Isiah III | director | Award / grant | 1,173 | 20,327 | Form 4 |
| 2026-06-10 | TESE VINCENT | director | Award / grant | 1,173 | 20,327 | Form 4 |
| 2026-06-10 | WEBER MARIANNE DOLAN | director | Award / grant | 1,173 | 20,327 | Form 4 |
| 2026-03-30 | Lo Allen M. | officer | Award / grant | 15,734 | 15,734 | Form 4 |
| 2026-03-13 | Koester Jennifer | officer | Withheld for tax | 8,808 | 30,918 | Form 4 |
| 2026-03-13 | Langer Robert H. | officer | Withheld for tax | 5,416 | 5,232 | Form 4 |
| 2026-03-13 | Granville-Smith David | officer | Withheld for tax | 3,688 | 56,464 | Form 4 |
| 2026-03-13 | Dolan Ryan Thomas | director | Withheld for tax | 325 | 4,059 | Form 4 |
| 2026-03-13 | Granville-Smith David | officer | Option exercise | 6,704 | 60,152 | Form 4 |
| 2026-03-13 | Dolan Ryan Thomas | director | Option exercise | 670 | 4,146 | Form 4 |
| 2026-03-13 | Dolan Ryan Thomas | director | Option exercise | 238 | 4,384 | Form 4 |
| 2026-03-13 | Dolan Ryan Thomas | director | Option exercise | 670 | 1,342 | Form 4 |
| 2026-03-13 | Dolan Ryan Thomas | director | Option exercise | 238 | 478 | Form 4 |
| 2026-03-13 | Koester Jennifer | officer | Option exercise | 17,254 | 39,726 | Form 4 |
| 2026-03-13 | Koester Jennifer | officer | Option exercise | 17,254 | 34,509 | Form 4 |
| 2026-03-13 | Langer Robert H. | officer | Option exercise | 10,648 | 21,298 | Form 4 |
| 2026-03-13 | Langer Robert H. | officer | Option exercise | 10,648 | 10,648 | Form 4 |
| 2026-03-13 | Granville-Smith David | officer | Option exercise | 6,704 | 13,410 | Form 4 |
| 2026-03-11 | Dolan Ryan Thomas | director | Award / grant | 2,391 | 2,391 | Form 4 |
| 2026-03-11 | Langer Robert H. | officer | Award / grant | 7,527 | 7,527 | Form 4 |
| 2026-03-11 | Granville-Smith David | officer | Award / grant | 7,527 | 7,527 | Form 4 |
| 2026-03-11 | Koester Jennifer | officer | Award / grant | 19,371 | 19,371 | Form 4 |
| 2026-03-11 | Winters Christopher J. | officer | Award / grant | 1,273 | 1,273 | Form 4 |
| 2026-02-17 | DOLAN JAMES LAWRENCE | director | Withheld for tax | 63,761 | 1,000,138 | Form 4 |
| 2026-02-17 | DOLAN JAMES LAWRENCE | director | Option exercise | 54,315 | 1,032,783 | Form 4 |
| 2026-02-17 | DOLAN JAMES LAWRENCE | director | Option exercise | 54,315 | 1,087,098 | Form 4 |
| 2026-02-17 | DOLAN JAMES LAWRENCE | director | Withheld for tax | 21,670 | 978,468 | Form 4 |
| 2026-02-17 | DOLAN JAMES LAWRENCE | director | Disposition | 11,600 | 1,075,499 | Form 4 |
| 2026-02-17 | DOLAN JAMES LAWRENCE | director | Disposition | 11,600 | 1,063,899 | Form 4 |
| 2026-02-17 | DOLAN JAMES LAWRENCE | director | Option exercise | 54,315 | 0 | Form 4 |
| 2025-10-17 | Dolan Ryan Thomas | director | Award / grant | 716 | 2,728 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.